ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

June 14, 2013

NCI Contract Awards

November 1, 1996

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

MD Anderson’s Balance Sheet is Issue No. 1 For DePinho’s “Moon Shots Program”

October 12, 2012

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

January 6, 1989